A detailed history of Candriam S.C.A. transactions in Abbott Laboratories stock. As of the latest transaction made, Candriam S.C.A. holds 359,676 shares of ABT stock, worth $40.8 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
359,676
Previous 303,509 18.51%
Holding current value
$40.8 Million
Previous $34.5 Million 8.34%
% of portfolio
0.23%
Previous 0.22%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$100.73 - $112.44 $5.66 Million - $6.32 Million
56,167 Added 18.51%
359,676 $37.4 Million
Q1 2024

May 03, 2024

SELL
$109.52 - $120.96 $35.4 Million - $39.1 Million
-322,925 Reduced 51.55%
303,509 $34.5 Million
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $10.7 Million - $13.1 Million
-119,098 Reduced 15.97%
626,434 $69 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $9.97 Million - $12 Million
-104,370 Reduced 12.28%
745,532 $72.2 Million
Q2 2023

Aug 08, 2023

SELL
$100.78 - $112.29 $4.7 Million - $5.23 Million
-46,599 Reduced 5.2%
849,902 $92.7 Million
Q1 2023

May 12, 2023

SELL
$96.86 - $114.01 $14.4 Million - $16.9 Million
-148,229 Reduced 14.19%
896,501 $90.8 Million
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $8.77 Million - $10.3 Million
-92,209 Reduced 8.11%
1,044,730 $115 Million
Q3 2022

Nov 10, 2022

BUY
$96.76 - $112.03 $28.4 Million - $32.9 Million
293,977 Added 34.87%
1,136,939 $110 Million
Q2 2022

Aug 03, 2022

BUY
$102.07 - $123.37 $3.1 Million - $3.75 Million
30,372 Added 3.74%
842,962 $91.6 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $3.07 Million - $3.74 Million
26,892 Added 3.42%
812,590 $96.2 Million
Q4 2021

Feb 10, 2022

BUY
$115.53 - $141.46 $23.6 Million - $28.9 Million
204,459 Added 35.18%
785,698 $111 Million
Q3 2021

Nov 09, 2021

SELL
$116.66 - $129.06 $9.25 Million - $10.2 Million
-79,305 Reduced 12.01%
581,239 $68.7 Million
Q2 2021

Jul 20, 2021

BUY
$105.79 - $124.53 $20.4 Million - $24 Million
192,623 Added 41.17%
660,544 $76.6 Million
Q1 2021

Apr 29, 2021

BUY
$108.84 - $128.23 $435 - $512
4 Added 0.0%
467,921 $49.2 Million
Q4 2020

Jan 22, 2021

SELL
$105.0 - $114.42 $13.9 Million - $15.2 Million
-132,853 Reduced 22.11%
467,917 $51.2 Million
Q3 2020

Oct 19, 2020

BUY
$91.64 - $111.29 $11.4 Million - $13.9 Million
124,711 Added 26.2%
600,770 $65.4 Million
Q2 2020

Jul 23, 2020

SELL
$76.57 - $98.0 $13.8 Million - $17.7 Million
-180,303 Reduced 27.47%
476,059 $43.5 Million
Q1 2020

May 26, 2020

BUY
$62.82 - $91.86 $1,005 - $1,469
16 Added 0.0%
656,362 $55.7 Million
Q4 2019

Jan 21, 2020

SELL
$78.51 - $87.4 $3.2 Million - $3.56 Million
-40,718 Reduced 5.84%
656,346 $57,000
Q3 2019

Oct 21, 2019

SELL
$81.84 - $88.74 $1.53 Million - $1.66 Million
-18,753 Reduced 2.62%
697,064 $58,000
Q2 2019

Aug 01, 2019

BUY
$72.88 - $85.0 $10.9 Million - $12.8 Million
150,066 Added 26.53%
715,817 $59.9 Million
Q1 2019

May 02, 2019

SELL
$66.22 - $80.06 $3.11 Million - $3.75 Million
-46,893 Reduced 7.65%
565,751 $45.2 Million
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $1.84 Million - $2.08 Million
28,026 Added 4.79%
612,644 $44.3 Million
Q3 2018

Nov 07, 2018

SELL
$60.81 - $73.36 $2.61 Million - $3.15 Million
-42,892 Reduced 6.84%
584,618 $42.9 Million
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $88,024 - $97,152
-1,529 Reduced 0.24%
627,510 $38.3 Million
Q1 2018

May 09, 2018

BUY
$56.27 - $63.62 $10.3 Million - $11.7 Million
183,537 Added 41.2%
629,039 $37.7 Million
Q4 2017

Feb 07, 2018

SELL
$53.68 - $57.47 $795,322 - $851,475
-14,816 Reduced 3.22%
445,502 $25.4 Million
Q3 2017

Nov 03, 2017

BUY
$48.06 - $53.64 $22.1 Million - $24.7 Million
460,318
460,318 $24.6 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.